13G Filing: Point72 Asset Management and Karyopharm Therapeutics Inc. (KPTI)

Page 11 of 11

Page 11 of 11 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: November 6, 2017
POINT72 ASSET MANAGEMENT, L.P.
By:  /s/ Kevin J. O’Connor                  
Name:  Kevin J. O’Connor
Title:  Authorized Person
POINT72 CAPITAL ADVISORS, INC.
By:  /s/ Kevin J. O’Connor                  
Name:  Kevin J. O’Connor
Title:  Authorized Person

CUBIST SYSTEMATIC STRATEGIES, LLC

By:  /s/ Kevin J. O’Connor                  
Name:  Kevin J. O’Connor
Title:  Authorized Person

POINT72 ASIA (HONG KONG) LIMITED

By:  /s/ Kevin J. O’Connor                  
Name:  Kevin J. O’Connor
Title:  Authorized Person

STEVEN A. COHEN

By:  /s/ Kevin J. O’Connor                  
Name:  Kevin J. O’Connor
Title:  Authorized Person

 

Page 11 of 11

Follow Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Page 11 of 11